Roivant Sciences Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Roivant Sciences Ltd in the first quarter 2026?
Roivant Sciences Ltd recorded a cumulative net loss of $-415 million during 12 months ending in the first quarter 2026, resulting in a negative return on equity (ROE) of -8.21%.

Within the Major Pharmaceutical Preparations industry 74 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 2633, from total ROE ranking in the fourth quarter 2025 at 3362.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 30 2026) I. Quarter	(Mar 31 2026) IV. Quarter	(Dec 31 2025) III. Quarter	(Sep 30 2025) II. Quarter	(Jun 30 2025) I. Quarter
Y / Y Equity Change	2.2 %	2.03 %	-19.56 %	-13.88 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-415	-398	-1,006	-574	-688
Return On Equity (TTM)	-8.21 %	-7.92 %	-20.12 %	-10.81 %	-12.49 %
ROIV's Total Ranking	# 2633	# 3362	# 2747	# 2792	# 2635
Equity (TTM) in Millions	4,922	5,292	5,187	4,805	4,816
Seq. Equity Change	-7 %	2.03 %	7.94 %	-0.22 %	-7.16 %
Seq. Net Income Change	-	-	-	-	-

Back to ROIV Management Effectiveness >> ROIV's 5 Years Annual ROE >> Compare ROIV ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 75
Sector	# 227
Overall	# 2633

Return On Equity Statistics
High	Average	Low
160.44 %	-4.17 %	-73.27 %
(Dec 31 2023)		(Dec 31 2022)

ROIV Annual Return On Equity	(Mar 31 2026) 2025	(Mar 31 2025) 2024	(Mar 31 2024) 2023	(Mar 31 2022) 2022
Total Equity in Millions	5,292	5,187	6,449	2,039	0
Y / Y Equity Change	2.03 %	-19.56 %	216.27 %	-	-
Net Income in Millions	-398	-357	4,231	-924	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-7.52 %	-6.88 %	65.62 %	-45.32 %	-

Back to ROIV Management Effectiveness >> ROIV's 5 Years Annual ROE >> Compare ROIV ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
ROIV's' Return on Equity at Yahoo Finance
ROIV's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for ROIV's Competitors
Subscribers only: Roe for Roivant Sciences Ltd 's Suppliers
Subscribers only: Return On Equity for ROIV's Customers

Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector

ROE

Date modified: 2026-09-05T15:28:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.